Abstract
Genome-wide association studies and subsequent replication studies have pinpointed 29 genetic variants associated with blood pressure (BP). None of these studies included North African populations. We therefore looked at whether or not these genetic variants modulated BP and hypertension (HTN) risk in an Algerian population sample. Twenty-nine single-nucleotide polymorphisms (SNPs) were genotyped in a representative sample of 787 subjects from the InSulino-résistance à ORan (ISOR) study (378 men and 409 women aged between 30 and 64 years and recruited from within the city of Oran, Algeria). Genetic variants were considered both individually and when combined as genetic predisposition scores (GPSs) for systolic BP (SBP), diastolic BP (DBP) and HTN risk. The SNPs in CYP1A1-ULK3, HFE and SH2B3 were significantly associated with BP and/or HTN. The SBP-GPS, DBP-GPS and HTN-GPS were associated with higher levels of DBP (+0.24 mm Hg P=0.05, +0.23 mm Hg P=0.05 and +0.26 mm Hg P=0.03, respectively). Moreover, the three GPSs tended to be associated with a 6% higher risk of HTN. Our study is the first to show that some of the BP loci validated in subjects of European descent were associated (either individually or when combined as GPSs) with BP traits and/or the HTN risk in an Algerian population, but to a lesser extent than in European populations. Although larger studies and meta-analyses of North African populations are needed to confirm the present results, our data contribute to a better understanding of genetic susceptibility to HTN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363–2369.
World Health Organization World Health Report Mental Health: New Understanding, New Hope. WHO: Geneva, Switzerland, 2001, 144–149.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
Whelton PK . Hypertension curriculum review: epidemiology and the prevention of hypertension. J Clin Hypertens 2004; 6: 636–642.
Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.
Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN et al. Prospective study of sudden cardiac death among women in the United States. Circulation 2003; 107: 2096–2101.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.
Chockalingam A, Campbell NR, Fodor JG . Worldwide epidemic of hypertension. Can J Cardiol 2006; 22: 553–555.
WHO. New data highlight increases in hypertension, diabetes incidence. Int J Health Care Qual 2012; 25.
TAHINA, Projet I-M-T. Synthèse Enquête Mortalité. Institut National de la Santé Publique: Alger, Algeria, 2005.
Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000; 36: 477–483.
Ehret GB . Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010; 12: 17–25.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41: 666–676.
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41: 677–687.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478: 103–109.
Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G et al. Replicating genotype-phenotype associations. Nature 2007; 447: 655–660.
Tobin MD, Sheehan NA, Scurrah KJ, Burton PR . Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24: 2911–2935.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413–2446.
Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR et al. Sugar-sweetened beverages and genetic risk of obesity. New Engl J Med 2012; 367: 1387–1396.
Hong KW, Go MJ, Jin HS, Lim JE, Lee JY, Han BG et al. Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and/or hypertension in two Korean cohorts. J Hum Hypertens 2010; 24: 367–372.
Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011; 43: 531–538.
Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, Musani SK et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet 2011; 20: 2273–2284.
Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN et al. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet 2013; 22: 1663–1678.
Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y . Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP investigative team. Hypertension 1995; 26: 886–890.
Ben Romdhane H, Ben Ali S, Skhiri H, Traissac P, Bougatef S, Maire B . Hypertension among Tunisian adults: results of the TAHINA project. Hypertens Res 2012; 35: 341–347.
Al-Nozha MM, Abdullah M, Arafah MR, Khalil MZ, Khan NB, Al-Mazrou YY . Hypertension in Saudi Arabia. Saudi Med J 2007; 28: 77–84.
Rampal L, Rampal S, Azhar MZ, Rahman AR . Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16440 subjects. Public Health 2008; 122: 11–18.
Mittal BV, Singh AK . Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis 2010; 55: 590–598.
Mounier-Vehier C, Amah G, Covillard J . Prise en charge de l'HTA essentielle et du niveau de risque cardiovasculaire: Enquête nationale PHENOMEN. Arch Mal Coeur Vaiss 2002; 95: 667–672.
Jaiswal AK, Gonzalez FJ, Nebert DW . Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science 1985; 228: 80–83.
Nebert DW, Dalton TP . The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006; 6: 947–960.
Fitau J, Boulday G, Coulon F, Quillard T, Charreau B . The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006; 281: 20148–20159.
Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 2002; 195: 1599–1611.
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399–408.
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C . Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118: 2679–2686.
Wain LV, Verwoert CG, O’Reilly PF, Shi G, Johnson T, Johnson AD et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 2011; 10: 1005–1012.
Havulinna AS, Kettunen J, Ukkola O, Osmond C, Eriksson JG, Kesäniemi YA et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 2013; 61: 987–994.
Acknowledgements
The ISOR project was funded through a collaboration agreement between the Direction de la Post-Graduation et de la Recherche-Formation (Algeria) and the Institut National de la Santé et de la Recherche Médicale (INSERM) (France). The work in France was also part-funded by INSERM. The work in Algeria was also part-funded by the Agence Thématique de Recherche en Sciences de la Santé and a grant from the Projets Nationaux de Recherche program run by the Algerian Direction Générale de la Recherche Scientifique et du Développement Technologique/Ministère de l’Enseignement Supérieur et de la Recherche Scientifique.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lardjam-Hetraf, S., Mediene-Benchekor, S., Ouhaibi-Djellouli, H. et al. Effects of established blood pressure loci on blood pressure values and hypertension risk in an Algerian population sample. J Hum Hypertens 29, 296–302 (2015). https://doi.org/10.1038/jhh.2014.81
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2014.81